LRRK2 and Parkinson disease: Similarly, increased LRRK2 autophosphorylation and Rab substrate phosphorylation can be detected in urinary exosomes from LRRK2 mutation PD patients33–37, but none of these urinary measures reliably stratify idiopathic PD patients who may benefit from LRRK2 inhibitor treatment approaches.